Clinical Trials Directory

Trials / Unknown

UnknownNCT03847948

Biological Factors Associated With Subclinical Valvular Thrombosis

Evaluation of Biological Factors Associated With Subclinical Valvular Thrombosis in pAtients With Severe aoRtic Stenosis Undergoing TAVI: START Trial

Status
Unknown
Phase
Study type
Observational
Enrollment
166 (estimated)
Sponsor
Hospital San Carlos, Madrid · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective, multicentric cohort study including 166 patients with symptomatic aortic stenosis treated with transcatheter aortic valve implantation (TAVI). \- The main objective is to determine whether the high residual platelet reactivity rates in patients undergoing TAVI is associated with the occurrence of clinical and / or subclinical prosthetic valve thrombosis measured by echocardiography and multi-slice computerized tomography

Detailed description

For the purpose of the study, platelet reactivity will be measured with the commercial kit PLT VASP/P2Y12 at baseline, 1day and 3 months postprocedure. Secondary objectives include: -Determine the variability of platelet aggregation measured at baseline before the procedure, 1-day post-procedure and at 3-6 and 1 year follow-up. * To determine whether the pro-thrombotic inflammatory response measured by the CD14 + and CD16 + quantification observed after TAVI is associated with the appearance of prosthetic thrombosis. * To evaluate the Correlation of Von Willebrand factor levels and distribution of Von Willebrand multimers with the appearance of prosthetic thrombosis at baseline before the procedure, 1-day post-procedure and at 3, 6 months follow-up and 1 year. * To determine whether the residual platelet reactivity rates in patients undergoing TAVI are associated with the occurrence of clinical events, at baseline before the procedure, 1-day post-procedure and at 3,6 months follow-up and 1 year * To evaluate the clinical factors associated with the appearance of early prosthetic thrombosis.

Conditions

Timeline

Start date
2018-06-01
Primary completion
2021-12-31
Completion
2022-03-31
First posted
2019-02-20
Last updated
2021-10-29

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT03847948. Inclusion in this directory is not an endorsement.